Implementing HLA-B*58:01 testing prior to allopurinol initiation in Malaysian primary care setting: A qualitative study from doctors’ and patients’ perspective
Introduction Allopurinol, the first-line treatment for chronic gout, is a common causative drug for severe cutaneous adverse reactions (SCAR). HLA-B*58:01 allele was strongly associated with allopurinol-induced SCAR in Asian countries such as Taiwan, Japan, Thailand and Malaysia. HLA-B*58:01 screeni...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
Public Library of Science
2024
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/44932/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|